TNIK&MAP4K4-IN-2, identified by its CAS number 2828567-39-9, is a chemical compound that serves as an inhibitor targeting specific kinases, particularly TNIK (TRAF2 and NCK interacting kinase) and MAP4K4 (Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4). These kinases are involved in various cellular processes, including signal transduction pathways that regulate cell growth, differentiation, and apoptosis. The compound is typically characterized by its molecular structure, which includes specific functional groups that confer its inhibitory properties. It is often studied in the context of cancer research and other diseases where aberrant kinase activity plays a critical role. The compound's efficacy, selectivity, and pharmacokinetic properties are essential for its potential therapeutic applications. As with many small molecule inhibitors, understanding its mechanism of action and biological effects is crucial for developing effective treatments targeting related pathways. Safety and toxicity profiles are also important considerations in the development and application of this compound in research and clinical settings.

TNIK&MAP4K4-IN-2

2828567-39-9: TNIK&MAP4K4-IN-2, identified by its CAS number 2828567-39-9, is a chemical compound that serves as an inhibitor targeting specific kinases, particularly TNIK (TRAF2 and NCK interacting kinase) and MAP4K4 (Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4). These kinases are involved in various cellular processes, including signal transduction pathways that regulate cell growth, differentiation, and apoptosis. The compound is typically characterized by its molecular structure, which includes specific functional groups that confer its inhibitory properties. It is often studied in the context of cancer research and other diseases where aberrant kinase activity plays a critical role. The compound's efficacy, selectivity, and pharmacokinetic properties are essential for its potential therapeutic applications. As with many small molecule inhibitors, understanding its mechanism of action and biological effects is crucial for developing effective treatments targeting related pathways. Safety and toxicity profiles are also important considerations in the development and application of this compound in research and clinical settings.

INS018 055

<p>INS018 055 (TNIK&amp;amp;MAP4K4-IN-2) is a TNIK and MAP4K4 inhibitor with anti-fibrotic activity.</p>

CAS 2828567-39-9

TNIK&MAP4K4-IN-2

INS018 055

Ref: 54-BUP20805

INS018 055

Ref: TM-T87545